Dynamic Apoptosis Detection Kit
Pre-clinical- Indications
- Cancer detection
Company intelligence / Profile preview
UR Advanced Therapeutics has developed a novel apoptosis detection kit that enables early identification of dying cells—potentially aiding early cancer diagnosis—which has been validated across several Indian laboratories. The company also develops synthetic peptides for tissue engineering with ongoing preclinical work. Their technology leverages AI-driven de novo protein design.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UR Advanced Therapeutics Private Limited.